The discovery of BMS-737 as a potent, CYP17 lyase-selective inhibitor for the treatment of castration-resistant prostate cancer

Autor: Padmakar Darne, Chetan, Velaparthi, Upender, Saulnier, Mark, Frennesson, David, Liu, Peiying, Huang, Audris, Tokarski, John, Fura, Aberra, Spires, Thomas, Newitt, John, Spires, Vanessa M., Obermeier, Mary T., Elzinga, Paul A., Gottardis, Marco M., Jayaraman, Lata, Vite, Gregory D., Balog, Aaron
Zdroj: In Bioorganic & Medicinal Chemistry Letters 1 November 2022 75
Databáze: ScienceDirect
Externí odkaz: